BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2012
View Archived Issues
Cortical thickness-based biomarker may predict cognitive decline in cognitively normal adults
Read More
New HCV NS5B inhibitors synthesized by Arrow Therapeutics and AstraZeneca
Read More
Prana receives FDA clearance to initiate study of PBT-2
Read More
Presurgical trial set to investigate MK-2206 in operable invasive cancer
Read More
University of Arizona scientists assess natural monoterpene in phase I trial
Read More
Dosing of VT-464 begins in phase I/II study
Read More
Epigenomics submits PMA filing for Epi proColon
Read More
FDA accepts Repros Therapeutics' IND for Proellex-V
Read More
Phase I/II study evaluates rintatolimod as adjuvant for HER2 vaccine
Read More
New class of tetracyclic benzothiazepines identified as promising antimalarial agents
Read More
Gilead Sciences discloses new HCV replication inhibitors
Read More
Novel NS5B inhibitors patented by Biota Scientific Management
Read More
Afraxis researchers prepare new serine/threonine-protein kinase PAK inhibitors
Read More
Profectus BioSciences begins immunization with HIV vaccine in phase I trial
Read More
Novel beta-secretase 1 inhibitors claimed by Janssen Pharmaceutica
Read More
Novel protein-tyrosine kinase inhibitors synthesized in China
Read More
AstraZeneca reports novel dipeptidyl peptidase 1 inhibitors
Read More
Oncodesign and Ipsen enter research collaboration on Parkinson's disease
Read More
Ironwood Pharmaceuticals and Bionomics collaborate on anxiolytics
Read More
Basilea Pharmaceutica to file for approval of two products this year
Read More
Data safety monitoring board reports no safety concerns for phase IIb eteplirsen trial
Read More
First patient vaccinated in study of DPX-Survivac cancer vaccine
Read More
NeuroGenetic Pharmaceuticals receives funds to support development of gamma-secretase modulator
Read More
ProFibrix's U.S. phase II study of Fibrocaps meets all endpoints
Read More
Circadian Technologies initiates first clinical study of VGX-100
Read More